For people who feel that health reform is going to be too expensive, another couple of billion just got added to the federal budget. Every little bit helps.
On September 2, pharma giant Pfizer issued a press release detailing a settlement with the Department of Justice for the marketing strategies they used for selling Bextra and a number of other drugs off-label without the FDA's approval. Bextra was a cox-2 inhibitor (type of NSAID) used for pain management, including back pain. Pfizer voluntarily took Bextra off the market in 2005 after it became evident that the drug's side effects included serious and even fatal cardiovascular problems. As mentioned above, the Pfizer-DOJ agreement was not limited to Bextra. Lyrica, a painkiller used for fibromyalgia and about 9 other drugs had been marketed inappropriately to the public.
| Vioxx Timeline | Back Pain | NSAIDs and Back Pain |
=======================
Stay up to date:
Subscribe to
the Back and Neck Pain newsletter
ANDJoin the
discussion in the Back and Neck Pain forum.
=======================
Wow! Great thnkniig! JK